Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Edwards Lifesciences Corporation (EW) had Income from Continuous Operations of $380.70M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$1.65B |
|
$380.70M |
|
$362.60M |
|
$1.29B |
|
$1.17B |
|
$477.60M |
|
$-18.60M |
|
$459.00M |
|
$582.60M |
|
$380.70M |
|
|
Income from Continuous Operations |
$380.70M |
$380.70M |
|
$525.38M |
|
$477.60M |
|
$518.50M |
|
579.20M |
|
580.70M |
|
$0.66 |
|
$0.66 |
|
| Balance Sheet Financials | |
$6.23B |
|
$1.82B |
|
$7.09B |
|
$13.32B |
|
$1.41B |
|
$598.50M |
|
$1.58B |
|
$2.99B |
|
$10.33B |
|
$7.28B |
|
$10.33B |
|
577.00M |
|
| Cash Flow Statement Financials | |
$43.80M |
|
$-92.80M |
|
$-451.20M |
|
$2.94B |
|
$2.45B |
|
$-492.00M |
|
$45.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.42 |
|
-- |
|
-- |
|
0.05 |
|
0.06 |
|
78.01% |
|
28.97% |
|
28.97% |
|
-- |
|
27.84% |
|
23.09% |
|
$-21.10M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.32 |
|
1.69 |
|
53.12 |
|
3.69% |
|
5.23% |
|
2.86% |
|
3.48% |
|
$17.90 |
|
$-0.04 |
|
$0.08 |
|